Aprogen Medicines Inc. (KRX:007460)

Aprogen Medicines Revenue

Aprogen Medicines had revenue of 26.73B KRW in the quarter ending March 31, 2025, a decrease of -29.82%. This brings the company's revenue in the last twelve months to 138.76B, down -9.13% year-over-year. In the year 2024, Aprogen Medicines had annual revenue of 150.11B, down -0.31%.

• Revenue (ttm): 138.76B
• Revenue Growth: -9.13%
• P/S Ratio: 1.41
• Revenue / Employee: 566.37M
• Employees: 245
• Market Cap: 195.89B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	150.11B	-464.40M	-0.31%
Dec 31, 2023	150.58B	72.23B	92.19%
Dec 31, 2022	78.35B	52.05B	197.95%
Dec 31, 2021	26.30B	-100.85B	-79.32%
Dec 31, 2020	127.14B	48.89B	62.48%